Azopharma Opens New Cyanta Analytical Lab Facility

Azopharma has opened a new Cyanta Analytical Laboratories facility in Maryland Heights, MO. The new 20,000-sq.-ft. lab is equipped with state-of-the-art instrumentation to support pharmaceutical and medical device product development, specifically analytical method development and inhalation/respiratory services.

Phil Meeks, chief executive officer of Azopharma, said, “With the opening of our new facility, Cyanta becomes the center of excellence for analytical support in the inhalation industry.” He added, “The new facilities have been modified and updated to meet the stringent demands of our pharmaceutical, medical device and biotech customers, and we will continue to adapt to meet their growing demands as necessary.”

The instrumentation additions include: Anderson and Next Generation Impactors for aerodynamic particle sizing, Proveris SprayView unit, Malvern SprayTech, walk-in stability chambers with standard ICH conditions, custom stability chambers that provide various temperatures and humidly conditions, stability and laboratory areas monitored by the Kaye LabWatch system, state-of-the-art GC/MS and LC/MS (Triple Quad, Ion Trap, Tandem MS, MSn) for structural characterization and elucidation, and gel permeation chromatography instrumentation.

Cyanta Analytical Laboratories provides analytical services to the pharmaceutical, biotech and medical device industries and its services focus on stand-alone analytical projects for pharmaceutical products and medical devices, either in development or currently marketed. Cyanta services support early to late phase projects including analytical development, method validation, stability testing, extractables and leachables, inhalation development services and analytical support for formulations.